Intra-Lesional Injection of the Novel PKC Activator EBC-46 Rapidly Ablates Tumors in Mouse Models
Glen M. Boyle(Queensland University of Technology), Peter G. Parsons(QIMR Berghofer Medical Research Institute)
Cited by 86
Related Papers
MITF and BRN2 contribute to metastatic growth after dissemination of melanoma
|Scientific Reports|2017|63
BRN2 expression increases anoikis resistance in melanoma
|Oncogenesis|2020|36
BRN2 and MITF together impact AXL expression in melanoma
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0